Life sciences organizations are redefining what field excellence means as healthcare professional expectations continue to evolve. Traditional engagement models are shifting, and pharmaceutical and biotech companies must rethink how life sciences field teams create value.
Our NEW Future of Field Excellence Report explores how life sciences organizations are responding to these changes and what it will take to close the gap between ambition and execution.
Building on insights from our 2024 Field Excellence Report, this new research highlights how leading organizations are evolving their field engagement strategies to better support commercial, medical affairs, and market access teams.
Research at a glance
- 100+ life sciences leaders and professionals surveyed
- 54 pharmaceutical and biotech companies represented
- Research conducted across EMEA, the US, Canada, APAC and LATAM.
- Perspectives from commercial, medical affairs, market access, and learning & development leaders
This global research provides a cross-functional view of how organizations are approaching field excellence in life sciences.
What you’ll learn
This report explores the forces reshaping field engagement in pharma and biotech, including:
- How organizations are redefining field excellence
- Capabilities needed for modern field teams
- Barriers preventing field impact
- Practical recommendations for strengthening field capabilities
The report also highlights five key trends shaping the future of field engagement across the life sciences industry.
Download now.
View more Inizio Engage insights.
Jump to a slide with the slide dots.
Katie Coleman
Where big work meets little minds: BYCTWD 2026
Bring Your Child to Work Day 2026 brought energy, creativity, and fresh perspectives to XD, as 43 young minds explored, created, and experienced the..
Read more
Forty1 strengthens North America leadership team with appointment of Principal Consultant
Forty1 strengthens its North America team with a new Principal Consultant, enhancing employee experience and transformation consulting capabilities.
Read more
Holly Spencer
We need to talk about the zebra in the room: ATTR-CM and the patients we’re missing
ATTR-CM may be described as rare, but many patients are simply going undiagnosed. Delayed recognition, fragmented care, and limited access continue...
Read more
Inizio Engage appoints Creative and Synthetic Leader as Executive Creative Director
Inizio Engage XD appoints Colin Melville as Executive Creative Director to lead AI-driven creativity, immersive experiences, and innovation globally.
Read more
Colin Melville Recognized in PM360’s 2025 ELITE 100 Awards for Disrupting Healthcare Storytelling
Colin Melville has been recognized in PM360’s ELITE 100 Awards for disrupting healthcare storytelling through generative AI and creative innovation.
Read more